The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
NU HLDGS LTD ORD SHS CL A G6683N103   19,546,131 1,431,951 SH   SOLE   1,431,951 0 0
AKERO THERAPEUTICS INC COM 00973Y108   12,160,228 423,849 SH   SOLE   423,849 0 0
89BIO INC COM 282559103   5,358,577 724,132 SH   SOLE   724,132 0 0
ISHARES TR CORE S&P500 ETF 464287200   32,925,462 57,081 SH   SOLE   57,081 0 0
MADRIGAL PHARMACEUTICALS INC COM 558868105   9,704,821 45,730 SH   SOLE   45,730 0 0
PEARL DIVER CREDIT COMPANY I COM SHS 70476Q100   29,199,012 1,459,221 SH   SOLE   1,459,221 0 0
SEA LTD SPONSORD ADS 81141R100   44,426,904 471,223 SH   SOLE   471,223 0 0